Navigation Links
Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology
Date:8/10/2011

iscovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX1031 and LX1033, including characterizations of the results of and projected timing of clinical trials of such compounds, and the potential therapeutic and commercial potential of LX1031 and LX1033. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX1031 and LX1033 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 2 Trial of Lexicons LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
2. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results
3. Lexicons IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
4. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
5. Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
6. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results
7. Lexicon to Provide First Quarter 2011 Financial Results
8. Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
9. Lexicon Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
11. Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... BILLERICA, Mass. , June 2, 2015 /PRNewswire/ ... of Merck KGaA of Darmstadt, ... technology that compacts dry powder cell culture media ... handling. The compacted media are therefore more convenient ... their upstream processes. Photo - ...
(Date:6/2/2015)... GATOS, Calif. , June 2, 2015 ... you to shift mental states in minutes; feeling more calm ... for the first time, the sleek and simple wearable is ... home, work, or while commuting. The neurosignaling device is operated ... you achieve calm or increase your energy level. ...
(Date:6/2/2015)... MADRID , June 2, 2015 /PRNewswire/ ... meeting annuale della American Society of Clinical Oncology    ... multicentrico di fase 3 SAR3007, resi noti dal dipartimento ... hanno evidenziato un significativo miglioramento della sopravvivenza libera da ... ) rispetto al trattamento con dacarbazina in pazienti con ...
Breaking Medicine Technology:EMD Millipore Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production 2EMD Millipore Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production 3Thync Launches First Wearable to Shift Your State of Mind 2Thync Launches First Wearable to Shift Your State of Mind 3Thync Launches First Wearable to Shift Your State of Mind 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6
... Md., March 26, 2012 MedImmune announced today it ... Online (NIC Online), from March 26 – 28, 2012.  ... attendees will participate in live or archived sessions entirely ... on pediatric influenza vaccination and the safety and efficacy ...
... International, Inc., a leading global supplier of medical imaging ... is has contributed $5000 to the American Cancer Society ... Key Gala, that benefits the Boston Hope Lodge, and ... 29, 2012. "We are pleased to make ...
Cached Medicine Technology:MedImmune to Present Nine Abstracts Related to Influenza Vaccination at First Online National Immunization Conference 2Quest International Donates $5000 to the American Cancer Society 2
(Date:6/2/2015)... June 02, 2015 Relias ... compliance solutions for the healthcare market, is partnering ... to offer 10 complimentary courses relating to mental ... safety professionals with additional resources to better understand ... are often the first responders to situations involving ...
(Date:6/2/2015)... LUSAKA, Zambia (PRWEB) June 02, 2015 ... agricultural businesses, today opened a new seed warehouse and ... capacity and meet farmer demand for both local and ... Africa. , “Zambia could emerge as the breadbasket ... fostered,” said Worede Woldemariam, East and South Central Africa ...
(Date:6/2/2015)... 02, 2015 Visiting Nurse Association ... of home health care, hospice and community services, ... CEO, Steve Landers, MD, MPH, to the Visiting ... , VNAA is a national association based ... mission driven, nonprofit providers of home and community-based ...
(Date:6/2/2015)... TranSlice: Reveal from Pixel Film Studios brings ... allows Final Cut Pro X users to transition from clip ... next screen. , TranSlice Reveal brings back the split screen ... X users can now transition from one screen to ... panel orientation and direction covered, no transition will look like ...
(Date:6/2/2015)... TX (PRWEB) June 02, 2015 FDA approved ... qualified Diet Doc patients after a satisfactory doctor consultation. The ... the market for several years and has the longest track ... to block the enzyme that breaks down fats in foods, ... them through the intestinal system to be excreted through feces. ...
Breaking Medicine News(10 mins):Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 3Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 2Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 3Health News:Announcing the release of TranSlice Reveal from Pixel Film Studios - Professional Split Screen Transitions for FCPX. 2Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 2Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 4
... Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that ... is scheduled to present a company overview at the 8th ... May 20th at 2:00 p.m. PT.To access the live audio ... www.rigel.com . Please connect to Rigel,s website several minutes prior ...
... Science Olympiad to Emphasize the Importance of Fueling Body ... you find America,s brightest young minds launching rockets, crashing ... are part of the 25th annual Science Olympiad National ... first time, the incredible edible egg, on behalf of ...
... ... San Bruno, CA (PRWEB) May 13, 2009 -- As many as 90 ... eMedicine from WebMD. AGE, an inflammation of the digestive ... Victims are usually hit by sudden onset diarrhea, and the most common ...
... 2009 at the MLA (Medical Library Association Annual Meeting and Exhibition) ... ... 2009 -- Existing health search engines often fail to provide relevant, ... that "the goal of HealthMash is to promote health and ...
... RIO DE JANEIRO, Brazil, May 12 Amilpar ... the largest managed care organization in Brazil, announced today its ... At the end of March, total membership ... 2.3% down on the 3.18 million recorded in the 4Q08.Adjusted ...
... to grain products cut congenital heart defects in newborns, researchers ... mandatory addition of folic acid to flour, pasta and other ... ago, fewer babies have been born with congenital heart defects, ... has been shown to reduce neural tube birth defects, such ...
Cached Medicine News:Health News:America's Top Young Scientists to Receive Scholarships for Winning Eggs-Periments 2Health News:America's Top Young Scientists to Receive Scholarships for Winning Eggs-Periments 3Health News:America's Top Young Scientists to Receive Scholarships for Winning Eggs-Periments 4Health News:When Stomach Flu Strikes, Work With, Not Against, Body's Natural Defenses 2Health News:Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009 2Health News:Folic Acid Reduces Infant Heart Defects 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: